Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06220721 · ClinicalTrials.gov registry record · NA
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
A NA study of Hypertension, Pregnancy Induced, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 618
- Enrollment target
- 2
- Study locations
NCT06220721: Recruiting NA study of Hypertension, Pregnancy Induced, sponsored by Medical College of Wisconsin.
NCT06220721 is a NA study of Hypertension, Pregnancy Induced that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 618 participants, above the 238-participant average among 7 other Hypertension, Pregnancy Induced trials with a reported enrollment target (160% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06220721, a NA study of Hypertension, Pregnancy Induced, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 618 participants
- Enrollment target
- 2
- Study locations
Study Summary
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
Primary Outcome
Diagnosis of chronic hypertension, defined as stage I hypertension with BP \>130/80 mmHg
Conditions Studied
Interventions
- DRUG Nifedipine ER
Study Locations (2)
Illinois
- Northwestern University - Chicago
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 618 participants |
| Start Date | 2024-10-23 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
What NCT06220721 shows while recruiting
NCT06220721 is an interventional study that assigns participants to a tested intervention. The registered 618 participants enrollment target is mid-sized for trials with a published cap, above the 238-participant average among 7 other Hypertension, Pregnancy Induced trials with a reported enrollment target (160% higher).
The record links to 1 condition, with Hypertension, Pregnancy Induced appearing as the primary indexed condition, and to 1 intervention - of which Nifedipine ER is the first listed.
NCT06220721 reports a single indexed study location in Illinois, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06220721 about?
NCT06220721 is a clinical study titled "Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia". The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of ...
What is the current status of trial NCT06220721?
This trial is currently recruiting. It is a NA study. The enrollment target is 618 participants. The study started on 2024-10-23. Estimated completion is 2029-06-30.
What conditions does trial NCT06220721 study?
This clinical trial studies the following conditions: Hypertension, Pregnancy Induced.
What interventions are being tested in trial NCT06220721?
The interventions under investigation include: Nifedipine ER (DRUG).
Who is sponsoring clinical trial NCT06220721?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06220721 being conducted?
This trial has 2 study locations across Illinois, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension, Pregnancy Induced
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Better Understanding Patient Perspectives of an Educational Tool for Postpartum Hypertensive Patients
ACTIVE NOT RECRUITING · NA
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05672927 · 618 participants · Phase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
- NCT02610179 · 617 participants · NA
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
- NCT02282969 · 620 participants
PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
- NCT02838836 · 620 participants
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI